Immunogenicity of Murine Solid Tumor Models as a Defining Feature of in Vivo Behavior and Response to Immunotherapy

Journal of immunotherapy (Hagerstown, Md. : 1997) - United States
doi 10.1097/01.cji.0000436722.46675.4a
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Systemic Delivery of chTNT-3/CpG Immunoconjugates for Immunotherapy in Murine Solid Tumor Models

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2016English

Endometrial Tumor Immune Response: Predictive Biomarker of Response to Immunotherapy

Clinical Cancer Research
Cancer ResearchOncology
2019English

Cytoreductive Chemotherapy Improves the Biodistribution of Antibodies Directed Against Tumor Necrosis in Murine Solid Tumor Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Turing Test as a Defining Feature of AI-Completeness

Studies in Computational Intelligence
Artificial Intelligence
2013English

Sex as a Predictor of Response to Cancer Immunotherapy

The Lancet Oncology
Oncology
2018English

Sex as a Predictor of Response to Cancer Immunotherapy

The Lancet Oncology
Oncology
2018English

Defining T Cell States Associated With Response to Checkpoint Immunotherapy in Melanoma

Cell
BiochemistryGeneticsMolecular Biology
2019English

Circulating Tumor DNA as an Early Indicator of Response to T-Cell Transfer Immunotherapy in Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2016English

Overcoming Tumor Hypoxia as a Barrier to Radiotherapy, Chemotherapy and Immunotherapy in Cancer Treatment

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy